stars 1 stars 2 stars 3

Cytocell was originally established in 1991 at Birmingham Heartlands Hospital before moving to Banbury, Oxfordshire in 1994. Located in Cambridge since 2003, Cytocell is now a significant European manufacturer of Fluorescence in situ Hybridisation (FISH) probes, with a well established worldwide product distribution network which covers more than 60 countries. Cytocell offers a comprehensive range of FISH probes, including FISH probes for constitutional cytogenetic and oncology (both pathology and haematology) applications. Cytocell also has a proprietary BAC clone collection, and offers a custom FISH probe design service - www.myprobes.com. Cytocell is registered with the Medicines and Healthcare products Regulatory Agency and all Cytocell products are CE marked in accordance with the In Vitro Diagnostic Medical Devices Directive 98/79/EC, and the 2002 Regulations. Cytocell also sells ASR’s (Analyte Specific Reagents) into the US. Cytocell operates a Quality Management System that has been assessed and certified to both EN ISO 9001:2008 and EN ISO 13485:2003.

Cytocell Questions

The Cytocell annual revenue was $5 million in 2026.

Martin Lawrie is the Owner of Cytocell.

6 people are employed at Cytocell.

Cytocell is based in Cambridge, Cambridgeshire.

The NAICS codes for Cytocell are [5417, 541713, 54171, 541, 54].

The SIC codes for Cytocell are [873, 87].

Top Cytocell Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users